Showing results (411-420 of 427) with videos related to
Sort By:
Pageof 43
Urology|March 28, 2019
Outcomes of Partial and Radical Nephrectomy in Octogenarians - A Multicenter International Study (Resurge)Alessandro Antonelli, Alessandro Veccia, Nicola Pavan, et al.Minerva Urology and Nephrology|April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 RegistryMariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.World Journal of Urology|April 18, 2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)Ahmed Eraky, Reuben Ben-David, Gabriele Bignante, et al.Future Oncology (London, England)|July 19, 2021
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapyMatteo Ferro, Giuseppe Lucarelli, Ottavio de Cobelli, et al.World Journal of Urology|October 6, 2022
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)Alessandro Tafuri, Michele Marchioni, Clara Cerrato, et al.World Journal of Urology|September 2, 2025
Radical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registryFrancesco Ditonno, Alessandro Veccia, Gabriele Bignante, et al.Urology Practice|June 22, 2026
Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registryFrancesco Ditonno, Alessandro Veccia, Giacomo Musso, et al.European Urology|May 23, 2018
Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group)Riccardo Bertolo, Riccardo Autorino, Giuseppe Simone, et al.Urologic Oncology|December 13, 2024
Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapyRoberto Contieri, Francesco Claps, Rodolfo Hurle, et al.Cancers|April 3, 2021
Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and MilanMaria J Monroy-Iglesias, Marta Tagliabue, Harvey Dickinson, et al.Pageof 43